The Motilal Oswal 30th Annual Wealth Creation Study (2020–2025) analyses the top 100 companies in India that have created the most wealth for investors over the last five years. Wealth creation is measured by the increase in market capitalisation, adjusted for corporate actions such as mergers, demergers, buybacks, capital issuance, and dividends.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,